Up­dat­ed: NJ court says drug­mak­ers can co­or­di­nate their le­gal fight against the gov­ern­men­t's price ne­go­ti­a­tions

Four ma­jor drug­mak­ers su­ing against the In­fla­tion Re­duc­tion Act will have their ar­gu­ments heard to­geth­er in court next month as part of a strat­e­gy le­gal ex­perts say could help bol­ster each oth­er’s cas­es.

De­spite op­po­si­tion from the fed­er­al gov­ern­ment, the com­pa­nies — Bris­tol My­ers Squibb, No­var­tis, No­vo Nordisk and J&J’s Janssen — con­vinced a fed­er­al judge in New Jer­sey to hear all of the cas­es over four hours on March 7, giv­en the “over­lap­ping na­ture” of their claims.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER